RXD vs. XTJL
RXD (ProShares UltraShort Health Care) and XTJL (Innovator U.S. Equity Accelerated Plus ETF - July) are both Leveraged Equities funds. RXD is passively managed, while XTJL is actively managed. Over the past 3 years, RXD returned -6.72%/yr vs 14.67%/yr for XTJL. At a correlation of -0.58, they often move in opposite directions. RXD charges 0.95%/yr vs 0.79%/yr for XTJL.
Performance
RXD vs. XTJL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, RXD achieves a 4.25% return, which is significantly lower than XTJL's 5.38% return.
RXD
- 1D
- -5.76%
- 1M
- -8.56%
- YTD
- 4.25%
- 6M
- 2.28%
- 1Y
- -22.97%
- 3Y*
- -6.72%
- 5Y*
- -7.99%
- 10Y*
- -19.08%
XTJL
- 1D
- 0.02%
- 1M
- 1.01%
- YTD
- 5.38%
- 6M
- 6.35%
- 1Y
- 15.58%
- 3Y*
- 14.67%
- 5Y*
- —
- 10Y*
- —
RXD vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | 4.25% | -21.66% | 4.83% | 3.25% | 1.20% | -18.91% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 5.38% | 15.42% | 14.43% | 25.72% | -15.66% | 7.28% |
Correlation
The correlation between RXD and XTJL is -0.33, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.33 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.45 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 2021 | -0.58 |
Over the past year, the inverse relationship between RXD and XTJL has weakened: their correlation has moved from -0.58 to -0.33, meaning they move in opposite directions less often than they have historically.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
RXD vs. XTJL — Risk / Return Rank
RXD
XTJL
RXD vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Health Care (RXD) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RXD | XTJL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.88 | ||
| Sortino ratioReturn per unit of downside risk | -4.06 | ||
| Omega ratioGain probability vs. loss probability | 0.89 | 1.46 | -0.57 |
| Calmar ratioReturn relative to maximum drawdown | -0.67 | 3.06 | -3.72 |
| Martin ratioReturn relative to average drawdown | -1.04 | 17.30 | -18.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| RXD | XTJL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.77 | 2.11 | -2.88 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.27 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.58 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.65 | 0.65 | -1.30 |
Drawdowns
RXD vs. XTJL - Drawdown Comparison
The maximum RXD drawdown since its inception was -99.65%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for RXD and XTJL.
Loading charts...
Drawdown Indicators
| RXD | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.65% | -23.24% | -76.41% |
Max Drawdown (1Y)Largest decline over 1 year | -34.63% | -5.12% | -29.51% |
Max Drawdown (3Y)Largest decline over 3 years | -36.60% | -16.70% | -19.90% |
Max Drawdown (5Y)Largest decline over 5 years | -40.53% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -90.64% | — | — |
Current DrawdownCurrent decline from peak | -99.61% | 0.00% | -99.61% |
Average DrawdownAverage peak-to-trough decline | -81.88% | -4.04% | -77.84% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 22.14% | 0.90% | +21.24% |
Volatility
RXD vs. XTJL - Volatility Comparison
ProShares UltraShort Health Care (RXD) has a higher volatility of 10.19% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 0.31%. This indicates that RXD's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| RXD | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.19% | 0.31% | +9.88% |
Volatility (6M)Calculated over the trailing 6-month period | 21.87% | 5.72% | +16.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 30.03% | 7.42% | +22.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.85% | 15.21% | +14.64% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.00% | 15.21% | +17.79% |
RXD vs. XTJL - Expense Ratio Comparison
RXD has a 0.95% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Dividends
RXD vs. XTJL - Dividend Comparison
RXD's dividend yield for the trailing twelve months is around 2.69%, while XTJL has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
RXD ProShares UltraShort Health Care | 2.69% | 3.29% | 4.36% | 3.17% | 0.67% | 0.00% | 0.17% | 1.73% | 0.22% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
RXD and XTJL have a correlation of -0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RXD has higher volatility (10.19%) compared to XTJL (0.31%). In terms of maximum drawdown, RXD dropped -99.65% vs XTJL's -23.24%.
On 3-year performance, XTJL leads with 14.67% vs -6.72% for RXD. On fees, XTJL is cheaper at 0.79% per year. On volatility, XTJL has been the lower-risk option at 0.31%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, XTJL has performed better with a 14.67% return vs -6.72%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XTJL is cheaper with a 0.79% expense ratio, compared with 0.95% for RXD.
RXD has the higher dividend yield at 2.69%, compared with 0.00% for XTJL.
They also come from different issuers: ProShares and Innovator. Their fees differ too: 0.95% for RXD and 0.79% for XTJL.
XTJL currently has the higher Sharpe Ratio (2.11 vs -0.77), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for RXD and XTJL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer